Trial site
Memorial Sloan Kettering Cancer Center at Westchester
Harrison, New York 10604, United StatesNot linked to an institution yet
- 2running trials
- 4closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Phase
- Phase 12 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 31 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Genentech, Inc.2 trials
- Hoffmann-La Roche2 trials
- Pfizer2 trials
Closed trials
Terminated
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma
NCT03530683· Phase 1· Pfizer· Source
Completed
PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma
NCT03269136· Phase 1· Pfizer· Source
Completed
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
NCT03274492· Phase 3· Hoffmann-La Roche· Source
Completed
A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
NCT02500407· Phase 1/2· Genentech, Inc.· Source
Report an error